Human T cell lymphotropic virus type 1 (HTLV-1) infection increases the CD4 count in human immunodeficiency virus type 1 (HIV-1) infected patients submitted to antiretroviral therapy (ARV)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Human T cell lymphotropic virus type 1 (HTLV-1) infection increases the CD4 count in human immunodeficiency virus type 1 (HIV-1) infected patients submitted to antiretroviral therapy (ARV) ; volume:11 ; number:1 ; day:7 ; month:1 ; year:2014 ; pages:1 ; date:1.2014
Retrovirology ; 11, Heft 1 (7.1.2014), 1, 1.2014
- Creator
-
Rego, Filipe FA
- Contributor
-
Alcantara, Luiz CJ
de Oliveira, Tulio
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-11-S1-P62
- URN
-
urn:nbn:de:1111-2016080735026
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rego, Filipe FA
- Alcantara, Luiz CJ
- de Oliveira, Tulio
- SpringerLink (Online service)
Other Objects (12)
Herpes simplex virus type 2 infection increases human immunodeficiency virus type 1 entry into human primary macrophages
Inhibitors of human immunodeficiency virus type I
Prevalence of GB virus type C in urban Americans infected with human immunodeficiency virus type 1
Replikation von "Human Immunodeficiency Virus Type 1" in primären humanen Blutmonocyten
APOBEC3G targets human T-cell leukemia virus type 1
Entry of human immunodeficiency virus type 1 in T-cells
How human T-cell leukemia virus type 1 induces diseases
Inhibition of human immunodeficiency virus type-1 by cdk inhibitors
Herpes Simplex Virus Type 1 Human Cervical Dorsal Root Ganglionitis
Human immunodeficiency virus type-1 episomal cDNA in semen
Preadaptation of Simian Immunodeficiency Virus SIVsmm Facilitated Env-Mediated Counteraction of Human Tetherin by Human Immunodeficiency Virus Type 2
Replication of human immunodeficiency virus type 1 in human t-cells expressing antisense RNA
Herpes simplex virus type 2 infection increases human immunodeficiency virus type 1 entry into human primary macrophages
Inhibitors of human immunodeficiency virus type I
Prevalence of GB virus type C in urban Americans infected with human immunodeficiency virus type 1
Replikation von "Human Immunodeficiency Virus Type 1" in primären humanen Blutmonocyten
APOBEC3G targets human T-cell leukemia virus type 1
Entry of human immunodeficiency virus type 1 in T-cells
How human T-cell leukemia virus type 1 induces diseases
Inhibition of human immunodeficiency virus type-1 by cdk inhibitors
Herpes Simplex Virus Type 1 Human Cervical Dorsal Root Ganglionitis
Human immunodeficiency virus type-1 episomal cDNA in semen
Preadaptation of Simian Immunodeficiency Virus SIVsmm Facilitated Env-Mediated Counteraction of Human Tetherin by Human Immunodeficiency Virus Type 2
Replication of human immunodeficiency virus type 1 in human t-cells expressing antisense RNA
Herpes simplex virus type 2 infection increases human immunodeficiency virus type 1 entry into human primary macrophages
Inhibitors of human immunodeficiency virus type I
Prevalence of GB virus type C in urban Americans infected with human immunodeficiency virus type 1
Replikation von "Human Immunodeficiency Virus Type 1" in primären humanen Blutmonocyten
APOBEC3G targets human T-cell leukemia virus type 1
Entry of human immunodeficiency virus type 1 in T-cells
How human T-cell leukemia virus type 1 induces diseases
Inhibition of human immunodeficiency virus type-1 by cdk inhibitors
Herpes Simplex Virus Type 1 Human Cervical Dorsal Root Ganglionitis
Human immunodeficiency virus type-1 episomal cDNA in semen
Preadaptation of Simian Immunodeficiency Virus SIVsmm Facilitated Env-Mediated Counteraction of Human Tetherin by Human Immunodeficiency Virus Type 2